Factors Associated with Osteoarthritis in Elderly People in Shanghai: A Cross-Sectional Study
Xueyao Liang,Bo Zheng,Xiyou Cao,Shuangfei Xu,Qiongmei Zhang,Qing Fei,Nanqian Lu,Kai Zhang,Qingchun Liu,Ying Han,Xiaoyin Hu,Weibing Wang,Bing Liu,Mengfan Li,Ying Wu,Yefeng Zhao
DOI: https://doi.org/10.1101/2023.09.28.23296309
2023-01-01
Abstract:Background Osteoarthritis (OA) is a degenerative disease of mostly’ middle-aged and elderly people that contributes a high burden of disease in China and worldwide. However, many putative risk factors associated with OA in elderly populations remain substantially unclear. Methods In our cross-sectional study, 2177 residents of the Putuo District of Shanghai aged 40 years and above were recruited to complete a questionnaire that queried basic health information and assessed the prevalence of OA. A non-conditional and an ordinal logistic regression model was used to analyze the associations between putative risk factors and the severity of confirmed OA. Results Among 2099 eligible participants, the average age was 65.21 years (41.4% were male), and 551 self-reported OA [prevalence = 26.25% (24.13, 28.51)]. The prevalence of knee OA were the most common (23.11%, 21.12 to 25.23). OA was associated with age ≥ 60 years (aOR = 1.56; 1.18, 2.07), overweight BMI (24∼27.9 kg/m2) (1.30; 1.02 to 1.65), female sex (1.66; 1.30 to 2.12), unmarried status (1.41; 1.03 to 1.90), a family history of OA (6.23; 4.17 to 9.38), two or more comorbidities (2.18; 1.52 to 3.11), and prior injury to any joint (12.02; 4.86 to 31.22). Conclusions Old age, Female sex,family history and multiple comorbidities were significant contributors to promote the severity of OA. Appropriate prevention and treatment strategies must be developed to reduce the burden of the disease. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement Yes ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the Ethics Committee of the Shanghai Putuo Liqun Hospital (No. RT-201911). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data cannot be shared publicly because of Ethics. Data are available on request from the corresponding author Yefeng Zhao(e-mail: zhaoyefeng2002{at}live.com.)and Dr.Weibing Wang (e-mail: wwb{at}fudan.edu.cn) for researchers who meet the criteria for access to confidential data.